Nanoparticles targeting the infarcted heart

Nano Letters

Volumn 11, Issue 10, 2011, Pages 4411-4414

  Dvir, Tal ^a,b   Bauer, Michael ^c   Schroeder, Avi ^a   Tsui, Jonathan H ^b   Anderson, Daniel G ^a   Langer, Robert ^a   Liao, Ronglih ^a,c   Kohane, Daniel S ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

anoparticles; argeting; Liposomes; yocardial infarction

Indexed keywords

ANGIOTENSIN II; ANOPARTICLES; ARGETING; CARDIAC CELL; IN-VITRO; IN-VIVO; INTRAVENOUS INJECTIONS; MYOCARDIAL INFARCTION; NANOPARTICULATE SYSTEM; OVER-EXPRESSION; THERAPEUTIC AGENTS; YOCARDIAL INFARCTION;

LIPOSOMES; NANOPARTICLES; PHOSPHOLIPIDS;

HEART;

CARDIOVASCULAR AGENT; LIPOSOME; NANOPARTICLE;

ANIMAL; ARTICLE; DRUG DELIVERY SYSTEM; HEART INFARCTION; HUMAN; RAT;

ANIMALS; CARDIOVASCULAR AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MYOCARDIAL INFARCTION; NANOPARTICLES; RATS;

EID: 80054038548     PISSN: 15306984     EISSN: 15306992     Source Type: Journal    
DOI: 10.1021/nl2025882     Document Type: Article

References (26)

1. American Heart Association. ((2006).
2. Ruvinov, E.; Dvir, T.; Leor, J.; Cohen, S. Myocardial repair: from salvage to tissue reconstruction Expert Rev. Cardiovasc. Ther. 2008, 6, 669-686
3. Sy, J. C. Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction Nat. Mater. 2008, 7, 863-868
4. Hsieh, P. C.; Davis, M. E.; Gannon, J.; MacGillivray, C.; Lee, R. T. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers J. Clin. Invest. 2006, 116, 237-248 (Pubitemid 43121809)
5. Ruvinov, E.; Leor, J.; Cohen, S. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model Biomaterials 2010, 31, 4573-4582
6. Ruvinov, E.; Leor, J.; Cohen, S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction Biomaterials 2011, 32, 565-578
7. Garbern, J. C.; Minami, E.; Stayton, P. S.; Murry, C. E. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium Biomaterials 2011, 32, 2407-2416
8. Yockman, J. W. Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct Gene Ther. 2009, 16, 127-135
9. Dvir, T. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 14990-14995
10. Fitzpatrick, J. R., III Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction J. Thorac. Cardiovasc. Surg. 2010, 140, 667-676
11. Miyagi, Y. Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold Biomaterials 2010, 31, 7684-7694
12. Mallidi, S. Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer Nano Lett 2009, 9, 2825-2831
13. Farokhzad, O. C. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 6315-6320
14. von Mehren, M.; Adams, G. P.; Weiner, L. M. Monoclonal antibody therapy for cancer Annu. Rev. Med. 2003, 54, 343-369 (Pubitemid 37386401)
15. Harel-Adar, T. Modulation of cardiac macrophages by phosphatidylserine- presenting liposomes improves infarct repair Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 1827-1832
16. Scott, R. C. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function FASEB J. 2009, 23, 3361-3367
17. Weis, S. M. Vascular permeability in cardiovascular disease and cancer Curr. Opin. Hematol. 2008, 15, 243-249 (Pubitemid 351509347)
18. Molavi, B.; Chen, J.; Mehta, J. L. Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H687-693
19. Greene, L. J.; Spadaro, A. C.; Martins, A. R.; Perussi De Jesus, W. D.; Camargo, A. C. Brain endo-oligopeptidase B: a post-proline cleaving enzyme that inactivates angiotensin I and II Hypertension 1982, 4, 178-184 (Pubitemid 12162015)
20. Dvir, T.; Benishti, N.; Shachar, M.; Cohen, S. A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration Tissue Eng. 2006, 12, 2843-2852 (Pubitemid 46141252)
21. Peer, D. Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2007, 2, 751-760 (Pubitemid 350223348)
22. Segers, V. F. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 2007, 116, 1683-1692 (Pubitemid 47537842)
23. Kuhn, B. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair Nat. Med. 2007, 13, 962-969 (Pubitemid 47222046)
24. Dvir, T.; Levy, O.; Shachar, M.; Granot, Y.; Cohen, S. Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly Tissue Eng. 2007, 13, 2185-2193 (Pubitemid 47404434)
25. Dvir, T.; Banghart, M. R.; Timko, B. P.; Langer, R.; Kohane, D. S. Photo-targeted nanoparticles Nano Lett. 2010, 10, 250-254
26. Bauer, M. Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice Circ. Res. 2011, 108, 908-916